We’re excited to join NCT Middle East 2026 in Abu Dhabi, UAE, November 10–11. We look forward to connecting with civil and military professionals, industry leaders, and first responders from across the region to discuss CBRNE advancements.
Visit us at Booth #11.
At our booth, you can learn more about our portfolio of medical countermeasures (MCMs) against CBRN threats, including treatments for nerve agent exposure and fentanyl poisoning, alongside our expanding trauma and analgesia portfolio. This pipeline includes morphine and ketamine autoinjectors for acute pain management and intramuscular tranexamic acid (TXA) for the treatment of major bleeding.
Rafa Biodefense autoinjector products are designed for the realities of the field, where responders need fast, dependable drug delivery under pressure and in austere conditions.
With U.S. FDA-approved products, active government development and procurement agreements worldwide, and proven large-scale manufacturing capabilities, Rafa is well positioned to support critical medical preparedness needs.
We invite you to stop by our booth, meet our team, and discuss how Rafa’s expertise and solutions can support your organization’s needs.
📩 Want to learn more or set up a meeting in Abu Dhabi? Reach out: biodefense@rafa.co.il
